{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:46:15Z","timestamp":1740138375188,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12013-021-01031-7","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T16:03:15Z","timestamp":1646064195000},"page":"435-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bisphosphonate of Zoledronate Has Antiapoptotic Effect on Hypoxia\/Reoxygenation Injury in Human Embryonic Stem Cell-Derived Cardiomyocytes Through Trk Signaling Pathway"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-4576","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-2984","authenticated-orcid":false,"given":"Wen-Shu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-5062","authenticated-orcid":false,"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"issue":"9932","key":"1031_CR1","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","volume":"383","author":"G Heusch","year":"2014","unstructured":"Heusch, G., Libby, P., Gersh, B., Yellon, D., Bohm, M., Lopaschuk, G., & Opie, L. (2014). Cardiovascular remodelling in coronary artery disease and heart failure. Lancet, 383(9932), 1933\u20131943.","journal-title":"Lancet"},{"issue":"2","key":"1031_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0032-1333543","volume":"39","author":"G Lippi","year":"2013","unstructured":"Lippi, G., Franchini, M. & & Cervellin, G. (2013). Diagnosis and management of ischemic heart disease. Seminars in Thrombosis and Hemostasis, 39(2), 202\u2013213.","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"3","key":"1031_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.disamonth.2012.12.004","volume":"59","author":"S Boateng","year":"2013","unstructured":"Boateng, S., & Sanborn, T. (2013). Acute myocardial infarction. Disease-A-Month, 59(3), 83\u201396.","journal-title":"Disease-A-Month"},{"issue":"7","key":"1031_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cpcardiol.2012.03.002","volume":"37","author":"TD Welch","year":"2012","unstructured":"Welch, T. D., Yang, E. H., Reeder, G. S. & & Gersh, B. J. (2012). Modern management of acute myocardial infarction. Current Problems in Cardiology, 37(7), 237\u2013310.","journal-title":"Current Problems in Cardiology"},{"issue":"7","key":"1031_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/clc.20922","volume":"34","author":"MF Minicucci","year":"2011","unstructured":"Minicucci, M. F., Azevedo, P. S., Polegato, B. F., Paiva, S. A., & Zornoff, L. A. (2011). Heart failure after myocardial infarction: clinical implications and treatment. Clinical Cardiology, 34(7), 410\u2013414.","journal-title":"Clinical Cardiology"},{"issue":"2","key":"1031_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/SAP.0b013e31825c089c","volume":"72","author":"AD Widgerow","year":"2014","unstructured":"Widgerow, A. D. (2014). Ischemia-reperfusion injury: influencing the microcirculatory and cellular environment. Annals of Plastic Surgery, 72(2), 253\u2013260.","journal-title":"Annals of Plastic Surgery"},{"issue":"1","key":"1031_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy, D. J., & Yellon, D. M. (2013). Myocardial ischemia-reperfusion injury: a neglected therapeutic target. Journal of Clin Investigation, 123(1), 92\u2013100.","journal-title":"Journal of Clin Investigation"},{"issue":"1821","key":"1031_CR8","doi-asserted-by":"publisher","first-page":"20152147","DOI":"10.1098\/rspb.2015.2147","volume":"282","author":"T Kennedy-Lydon","year":"2015","unstructured":"Kennedy-Lydon, T., & Rosenthal, N. (2015). Cardiac regeneration: epicardial mediated repair. Proceedings of the Royal Society B: Biological Sciences, 282(1821), 20152147.","journal-title":"Proceedings of the Royal Society B: Biological Sciences"},{"issue":"1","key":"1031_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3727\/096368912X653282","volume":"22","author":"A Mehta","year":"2013","unstructured":"Mehta, A., & Shim, W. (2013). Cardiac stem cell therapy: stemness or commitment? Cell Transplantation, 22(1), 1\u201314.","journal-title":"Cell Transplantation"},{"issue":"2","key":"1031_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/trf.12826","volume":"55","author":"PP Young","year":"2015","unstructured":"Young, P. P., & Schafer, R. (2015). Cell-based therapies for cardiac disease: a cellular therapist\u2019s perspective. Transfusion, 55(2), 441\u2013451. quiz 440.","journal-title":"Transfusion"},{"issue":"5","key":"1031_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00018-009-8476-0","volume":"66","author":"A Beqqali","year":"2009","unstructured":"Beqqali, A., van Eldik, W., Mummery, C. & & Passier, R. (2009). Human stem cells as a model for cardiac differentiation and disease. Cellular and Molecular Life Sciences, 66(5), 800\u2013813.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"1031_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0008-6363(03)00264-5","volume":"58","author":"SG Nir","year":"2003","unstructured":"Nir, S. G., David, R., Zaruba, M., Franz, W. M., & Itskovitz-Eldor, J. (2003). Human embryonic stem cells for cardiovascular repair. Cardiovascular Research, 58(2), 313\u2013323.","journal-title":"Cardiovascular Research"},{"key":"1031_CR13","doi-asserted-by":"publisher","first-page":"512831","DOI":"10.1155\/2014\/512831","volume":"2014","author":"I Acimovic","year":"2014","unstructured":"Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014). Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomedical Research International, 2014, 512831.","journal-title":"Biomedical Research International"},{"issue":"9","key":"1031_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nbt1327","volume":"25","author":"MA Laflamme","year":"2007","unstructured":"Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., & Police, S., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015\u20131024.","journal-title":"Nature Biotechnology"},{"issue":"3","key":"1031_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCRESAHA.109.208991","volume":"106","author":"JV Terrovitis","year":"2010","unstructured":"Terrovitis, J. V., Smith, R. R., & Marban, E. (2010). Assessment and optimization of cell engraftment after transplantation into the heart. Circulation Research, 106(3), 479\u2013494.","journal-title":"Circulation Research"},{"issue":"19","key":"1031_CR16","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","volume":"50","author":"O Caspi","year":"2007","unstructured":"Caspi, O., Huber, I., Kehat, I., Habib, M., Arbel, G., Gepstein, A., Yankelson, L., Aronson, D., Beyar, R., & Gepstein, L. (2007). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. Journal of American College of Cardiology, 50(19), 1884\u20131893.","journal-title":"Journal of American College of Cardiology"},{"issue":"1","key":"1031_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/fca.10.109","volume":"7","author":"RJ Henning","year":"2011","unstructured":"Henning, R. J. (2011). Stem cells in cardiac repair. Future Cardiology, 7(1), 99\u2013117.","journal-title":"Future Cardiology"},{"issue":"2","key":"1031_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/CIA.S2134","volume":"3","author":"O Bock","year":"2008","unstructured":"Bock, O., & Felsenberg, D. (2008). Bisphosphonates in the management of postmenopausal osteoporosis\u2013optimizing efficacy in clinical practice. Clinical Interventions in Aging, 3(2), 279\u2013297.","journal-title":"Clinical Interventions in Aging"},{"issue":"Suppl 4","key":"1031_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","volume":"9","author":"RE Coleman","year":"2004","unstructured":"Coleman, R. E. (2004). Bisphosphonates: clinical experience. Oncologist, 9(Suppl 4), 14\u201327.","journal-title":"Oncologist"},{"issue":"10","key":"1031_CR20","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, G. D., Mundy, G. R., & Boyce, B. F. (1995). Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. Journal of Bone Mineral Research, 10(10), 1478\u20131487.","journal-title":"Journal of Bone Mineral Research"},{"key":"1031_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-83668-8_1","volume":"116","author":"H Fleisch","year":"1989","unstructured":"Fleisch, H. (1989). Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Recent Results in Cancer Research, 116, 1\u201328.","journal-title":"Recent Results in Cancer Research"},{"issue":"4","key":"1031_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jc.2009-1947","volume":"95","author":"NB Watts","year":"2010","unstructured":"Watts, N. B. & & Diab, D. L. (2010). Long-term use of bisphosphonates in osteoporosis. The Journal of Clinical Endocrinology and Metabolism, 95(4), 1555\u20131565.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"1031_CR23","doi-asserted-by":"publisher","first-page":"e41065","DOI":"10.1371\/journal.pone.0041065","volume":"7","author":"SH Tsai","year":"2012","unstructured":"Tsai, S. H., Huang, P. H., Chang, W. C., Tsai, H. Y., Lin, C. P., Leu, H. B., Wu, T. C., Chen, J. W., & Lin, S. J. (2012). Zoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cells. PLoS One, 7(7), e41065.","journal-title":"PLoS One"},{"key":"1031_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fnmol.2020.00087","volume":"13","author":"R Seist","year":"2020","unstructured":"Seist, R., Tong, M., Landegger, L. D., Vasilijic, S., Hyakusoku, H., Katsumi, S., McKenna, C. E., Edge, A. S. B., & Stankovic, K. M. (2020). Regeneration of cochlear synapses by systemic administration of a bisphosphonate. Frontiers in Molecular Neuroscience, 13, 87.","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"1031_CR25","unstructured":"Guide for the Care and Use of Laboratory Animals. edn. Washington (DC); 1996."},{"key":"1031_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-1-61779-201-4_31","volume":"767","author":"WZ Zhu","year":"2011","unstructured":"Zhu, W. Z., Van Biber, B., & Laflamme, M. A. (2011). Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods in Molecular Biology, 767, 419\u2013431.","journal-title":"Methods in Molecular Biology"},{"issue":"2","key":"1031_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/btpr.2039","volume":"31","author":"A Hsieh","year":"2015","unstructured":"Hsieh, A., Feric, N. T., & Radisic, M. (2015). Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro. Biotechnology Progess, 31(2), 482\u2013492.","journal-title":"Biotechnology Progess"},{"issue":"6","key":"1031_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.5966\/sctm.2013-0189","volume":"3","author":"J Luo","year":"2014","unstructured":"Luo, J., Weaver, M. S., Cao, B., Dennis, J. E., Van Biber, B., Laflamme, M. A., & Allen, M. D. (2014). Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia\/reoxygenation injury in vitro and increases graft size and vascularization in vivo. Stem Cells Translational Medicine, 3(6), 734\u2013744.","journal-title":"Stem Cells Translational Medicine"},{"issue":"8","key":"1031_CR29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10495-006-7786-z","volume":"11","author":"HC Wang","year":"2006","unstructured":"Wang, H. C., Zhang, H. F., Guo, W. Y., Su, H., Zhang, K. R., Li, Q. X., Yan, W., Ma, X. L., Lopez, B. L., & Christopher, T. A., et al. (2006). Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis, 11(8), 1453\u20131460.","journal-title":"Apoptosis"},{"issue":"3","key":"1031_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/14653240701247838","volume":"9","author":"J Cai","year":"2007","unstructured":"Cai, J., Yi, F. F., Yang, X. C., Lin, G. S., Jiang, H., Wang, T., & Xia, Z. (2007). Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts. Cytotherapy, 9(3), 283\u2013291.","journal-title":"Cytotherapy"},{"issue":"7","key":"1031_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3727\/000000003108747361","volume":"12","author":"H Huwer","year":"2003","unstructured":"Huwer, H., Winning, J., Vollmar, B., Welter, C., Lohbach, C., Menger, M. D., & Schafers, H. J. (2003). Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats. Cell Transplantation, 12(7), 757\u2013767.","journal-title":"Cell Transplantation"},{"key":"1031_CR32","doi-asserted-by":"crossref","unstructured":"Fazmin, IT, Huang, CL, Jeevaratnam, K. Bisphosphonates and atrial fibrillation: revisiting the controversy. Annals of the New York Academy of Sciences, 2020.","DOI":"10.1111\/nyas.14332"},{"issue":"3","key":"1031_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2165\/00002018-200932030-00004","volume":"32","author":"YK Loke","year":"2009","unstructured":"Loke, Y. K., Jeevanantham, V., & Singh, S. (2009). Bisphosphonates and atrial fibrillation: systematic review and meta-analysis. Drug Safety, 32(3), 219\u2013228.","journal-title":"Drug Safety"},{"issue":"3","key":"1031_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00520-010-0868-z","volume":"19","author":"C Arslan","year":"2011","unstructured":"Arslan, C., Aksoy, S., Dizdar, O., Dede, D. S., Harputluoglu, H., & Altundag, K. (2011). Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer, 19(3), 425\u2013430.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1031_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5152\/akd.2014.5333","volume":"15","author":"ZD Ilgezdi","year":"2015","unstructured":"Ilgezdi, Z. D., Aktas, I., Dogan Metin, F., Kepez, A., Unlu Ozkan, F., Silte, A. D., Yilmaz Kaysin, M., Kivrak, T., Cincin, A., & Erdogan, O. (2015). Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis. The Anatolian Journal of Cardiology, 15(4), 320\u2013324.","journal-title":"The Anatolian Journal of Cardiology"},{"key":"1031_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.freeradbiomed.2019.09.033","volume":"145","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Wang, S. P., Shao, Q., Li, P. F., Sun, Y., Luo, L. Z., Yan, X. Q., Fan, Z. Y., Hu, J. & & Zhao, J. et al. (2019). Brain-derived neurotrophic factor mimetic, 7,8-dihydroxyflavone, protects against myocardial ischemia by rebalancing optic atrophy 1 processing. Free Radical Biology and Medicine, 145, 187\u2013197.","journal-title":"Free Radical Biology and Medicine"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-01031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-021-01031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-01031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:30:07Z","timestamp":1650594607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-021-01031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1031"],"URL":"https:\/\/doi.org\/10.1007\/s12013-021-01031-7","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"type":"print","value":"1085-9195"},{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"16 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}